NCT06548347 2024-08-12A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell LymphomaShanghai YingLi Pharmaceutical Co. Ltd.Phase 2/3 Not yet recruiting606 enrolled